Hawktail • Seed Stage VC
Description: Rezo is pioneering an integrated approach to drug discovery to enabling the pinpointing of targets and the development of therapies with unprecedented clarity and speed.
Deep insights into underlying disease biology remains elusive, slowing innovation. Rezo is pioneering an integrated approach to drug discovery that leverages cutting-edge technologies to bring disease networks into focus, enabling the pinpointing of targets and the development of therapies with unprecedented clarity and speed.
Rezo’s Differentiated Approach to Tackling Disease
Rezo is tackling some of the most difficult challenges in medicine by mapping and therapeutically targeting networks that go awry in disease. Starting with genomic data, Rezo integrates distinct, unbiased technologies coupled with artificial intelligence to identify targets and therapies. Based on pioneering work from the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco, our mission is to break the mold in traditional drug development through the convergence of distinc
Hawktail • Seed Stage VC